Core Insights - Xtant Medical Holdings, Inc. has completed the sale of certain non-core Coflex spinal implant assets and all OUS entities of Paradigm Spine GmbH to Companion Spine, LLC for approximately $19.2 million, which includes $11.0 million in cash and $8.2 million in short-term seller financing [2][3] Financial Details - The transaction's purchase price consists of $11.0 million in cash and $8.2 million in an unsecured promissory note, which is subject to purchase price adjustments and matures on January 15, 2026 [2] - The net proceeds from the sale will be used to reduce long-term debt and enhance cash liquidity for the company [2] Strategic Focus - The sale is viewed as a significant step for Xtant Medical to enhance its focus on its core biologics business, aiming to drive innovation and improve financial performance [3] - The company expects that the net proceeds, along with anticipated cash flows from operations, will allow it to operate without needing additional external capital [3] Company Overview - Xtant Medical is a global medical technology company dedicated to surgical solutions for spinal and orthopedic conditions, with a mission centered on honoring the gift of donation to improve patients' lives [4]